670 results on '"Caljon, Guy"'
Search Results
2. Q586B2 is a crucial virulence factor during the early stages of Trypanosoma brucei infection that is conserved amongst trypanosomatids
3. A breath of fresh air: impact of insect-borne protozoan parasites on the respiratory system
4. The ongoing risk of Leishmania donovani transmission in eastern Nepal: an entomological investigation during the elimination era
5. Synthesis and pharmacological evaluation of fluoro/chloro-substituted acetyl and benzoyl esters of quinine as antimalarial agents
6. Open Synthesis Network Research in an Undergraduate Laboratory: Development of Benzoxazole Amide Derivatives against 'Leishmania' Parasite
7. Comparative genomic analysis of six Glossina genomes, vectors of African trypanosomes
8. Hit-to-lead optimization of a 2-aminobenzimidazole series as new candidates for chagas disease
9. Acyloxymethyl and alkoxycarbonyloxymethyl prodrugs of a fosmidomycin surrogate as antimalarial and antibacterial agents
10. Spliced-Leader RNA as a Dynamic Marker for Monitoring Viable Leishmania Parasites During and After Treatment
11. Dengue Virus Serotype 1 Effects on Mosquito Survival Differ among Geographically Distinct Aedes aegypti Populations
12. Synthesis and Anti-Trypanosoma cruzi Activity of 3-Cyanopyridine Derivatives
13. The Glossina Genome Cluster: Comparative Genomic Analysis of the Vectors of African Trypanosomes
14. Nucleoside analogues for the treatment of animal trypanosomiasis
15. 3-nitroimidazo[1,2-b]pyridazine as a novel scaffold for antiparasitics with sub-nanomolar anti-Giardia lamblia activity
16. Exploration of 6-methyl-7-(Hetero)Aryl-7-Deazapurine ribonucleosides as antileishmanial agents
17. Long-term hematopoietic stem cells as a parasite niche during treatment failure in visceral leishmaniasis
18. Impact of pulmonary African trypanosomes on the immunology and function of the lung
19. N6-modification of 7-Deazapurine nucleoside analogues as Anti-Trypanosoma cruzi and anti-Leishmania agents: Structure-activity relationship exploration and In vivo evaluation
20. Antiplasmodial activity of constituents and their metabolites after in vitro gastrointestinal biotransformation of a Nauclea pobeguinii extract
21. Hydrazinated geraniol derivatives as potential broad‐spectrum antiprotozoal agents.
22. Effect of Leishmania infantum infection on B cell lymphopoiesis and memory in the bone marrow and spleen.
23. N‐Pyrazolyl‐ and N‐Triazolylamines and ‐Ureas as Antileishmanial and Antitrypanosomal Drugs.
24. 6-Methyl-7-deazapurine nucleoside analogues as broad-spectrum antikinetoplastid agents
25. Long-term hematopoietic stem cells trigger quiescence in Leishmania parasites
26. Practical and Divergent Synthesis of Carbocyclic Pyrazolo[3,4‐d]pyrimidine Nucleoside Analogues
27. N6-Methyltubercidin gives sterile cure in a cutaneous Leishmania amazonensis mouse model
28. Assessing Environmental Risks during the Drug Development Process for Parasitic Vector-Borne Diseases: A Critical Reflection
29. Novel quinoline derivatives with broad‐spectrum antiprotozoal activities
30. Lead Optimization of the 5-Phenylpyrazolopyrimidinone NPD-2975 toward Compounds with Improved Antitrypanosomal Efficacy
31. Synthesis and evaluation of 3′-fluorinated 7-deazapurine nucleosides as antikinetoplastid agents
32. Synthesis and evaluation of a collection of purine-like C-nucleosides as antikinetoplastid agents
33. Assessing Environmental Risks during the Drug Development Process for Parasitic Vector-Borne Diseases: A Critical Reflection
34. Metronidazole Interaction with Cu2+ and Zn2+: Speciation Study in Aqueous Solution and Biological Activity Evaluation.
35. In Vivo Bioluminescence Imaging Reveals Differences in Leishmania infantum Parasite Killing Kinetics by Antileishmanial Reference Drugs.
36. Design and Synthesis of 1,3-Diarylpyrazoles and Investigation of Their Cytotoxicity and Antiparasitic Profile.
37. Sand Fly Studies Predict Transmission Potential of Drug-resistant Leishmania
38. Synthesis and structure activity relationships of cyanopyridone based anti-tuberculosis agents
39. Impact of clinically acquired miltefosine resistance by Leishmania infantum on mouse and sand fly infection
40. C6–O-alkylated 7-deazainosine nucleoside analogues: Discovery of potent and selective anti-sleeping sickness agents
41. Late‐Stage Diversification of Pyrazoles as Antileishmanial Agents
42. Naloxonazine, an Amastigote-Specific Compound, Affects Leishmania Parasites through Modulation of Host-Encoded Functions
43. Dual N6/C7-Substituted 7-Deazapurine and Tricyclic Ribonucleosides with Affinity for G Protein-Coupled Receptors
44. DNDI-6174 is a preclinical candidate for visceral leishmaniasis that targets the cytochrome bc 1
45. Synthesis and pharmacological evaluation of fluoro/chloro-substituted acetyl and benzoyl esters of quinine as antimalarial agents
46. Design and synthesis of imidazo[1,2‐a]pyridine‐chalcone conjugates as antikinetoplastid agents
47. Impaired development of a miltefosine-resistant Leishmania infantum strain in the sand fly vectors Phlebotomus perniciosus and Lutzomyia longipalpis
48. The Challenges of Effective Leishmaniasis Treatment
49. Characterization of the role of N-glycosylation sites in the respiratory syncytial virus fusion protein in virus replication, syncytium formation and antigenicity
50. Revisiting tubercidin against kinetoplastid parasites: Aromatic substitutions at position 7 improve activity and reduce toxicity
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.